In an ever-changing world, it is important to keep up with the latest innovations. In the never-ending search for what’s new, what better way to learn about it than to hear from the innovators themselves
Dr. Gonçalo Cotovio is a psychiatrist and clinical researcher at the Champalimaud Foundation Neuropsychiatry Unit, where he focuses on the neurobiology of mood and neuropsychiatric disorders, particularly brain connectivity and neuromodulation. He earned his MD from NOVA Medical School in 2014 and completed his PhD in 2023 with a scholarship from Fundação para a Ciência e Tecnologia.
He received advanced training in neuromodulation at Harvard Medical School and completed a program in Epidemiology and Clinical Research there in 2020. In 2024, he finished his Psychiatry residency in Lisbon. He is also an Assistant Professor of Neurosciences and Psychiatry at NOVA Medical School and was awarde a 2023 BBRF Young Investigator Grant.
Dr. sc. hum. Henrik Jungaberle is founder and Executive Director of the European non-profit MIND Foundation and the Head of Strategic Development at OVID Clinic Berlin – both dedicated to bringing medical psychedelic therapy into healthcare as well as building the science for safe and evidence-based forms of non-clinical use of psychedelics. He is a researcher in public health, psychedelics, and psychotherapy – and a science entrepreneur since 2016.
Henrik's interest is in human development, integration, and integrity in the use of psychedelic substances – and how to shape this on the individual, clinical, social, and regulatory levels.
Dr. Ivanka Savic is a professor of Neurology and chief clinician at Karolinska Institute, specializing in brain imaging, gender differences, epilepsy, and stress.
She pioneered the use of Flumazenil PET in epilepsy and was the first to study brain responses to human pheromones. Her work has shaped understanding of sex, gender, and self-perception in the brain.
Recently, she has focused on the impact of psychosocial stress. Her research is widely published and featured in major media outlets like CNN, The New York Times, and The Economist.
Dr. John W. Krakauer is the John C. Malone Professor of Neurology, Neuroscience, and Physical Medicine & Rehabilitation at Johns Hopkins University. He studied at Trinity College, Cambridge, and earned his MD from Columbia University, where he also trained in neurology and stroke. He directs the Center for Motor Learning and Brain Repair and leads the BLAM Lab, focusing on motor control, learning, and stroke recovery through immersive gaming, robotics, and brain stimulation. He also directs the Programme for Neuroscience of Disease at the Champalimaud Foundation, applying technologies like VR and brain-computer interfaces to clinical care. Dr. Krakauer actively engages in discussions on Al and its impact on brain health and medicine.
Márcio Debiasi is a Medical Oncologist at the Champalimaud Foundation, fully dedicated to the treatment and research of breast cancer. Holding both a Master of Science and a PhD in Epidemiology, his work lies at the intersection of clinical practice and translational research, with a strong focus on evidence-based medicine.
He is the Director of the Translational Research and Evidence-Based Medicine Group within the Breast Cancer Research Group at the Champalimaud Foundation and serves as the Principal Investigator of the KeyPARTNER Trial.
Dr. Gonçalves, cardiologist at Lariboisière-Saint Louis Hospital (APHP, Paris), specializes in cardiovascular imaging (echo, CMR,CT) and cardio-oncology, leading the unit managing cancer therapy complications. After earning her MD (2015) and completing cardiology residency (2020) at the University of Lorraine, she trained in biostatistics, now focuses on machine learning as a PhD student applying it to cardio-oncology. She also serves on the COOL Group Nucleus to promote cardio-oncology internationally.
Dr. Jan Theys, Associate Professor and Head of Precision Medicine at Maastricht University, is also Director of Education for Biomedical Sciences, Program Leader for Basic and Translational Cancer at GROW, M-Lab group leader, and Chair of the BMS Management Team. Trained at KU Leuven (PhD 2001), he pioneered Clostridium-mediated tumor-selective therapy and now focuses on metabolic drivers of tumor progression and resistance, advancing oncometabolic research into personalized treatments through major grants and partnerships.
Dr. Pedro Meireles is a Medical Oncologist specializing in breast, gynecologic, and hereditary cancers, combining clinical practice, research, and teaching. He has served as an investigator in multiple clinical trials, presented at national and international oncology meetings, and collaborated with industry to advance cancer care. Holding a Master's in Palliative Care focused on clinical communication,
he lectures at the University of Lisbon, teaching medical students soft skills and supervising theses in communication and palliative care. His work integrates scientific rigor with human-centered care to improve cancer treatment and patient support.
Dr. Nuno Gaibino is an Intensive Care Physician and Assistant Professor at the Faculty of Medicine, University of Lisbon (FMUL), currently working at the Intensive Care Department of Centro Hospitalar Universitário Lisboa Norte – Hospital de Santa Maria. He also serves as a physician on the Emergency and Resuscitation Medical Vehicle (VMER) of the Portuguese National Institute of Medical Emergency (INEM) and as an instructor in Advanced Life Support (AHA, INEM) and pre-hospi-tal emergency courses.
In 2024, he was appointed National Transplant Coordinator at the Portuguese Institute of Blood and Transplantation (IPST), where he combines clinical, educational, and coordination roles in intensive care and organ transplantation.
Rob Tidwell is a consultant in Intensive Care Medicine at University College London Hospital specialising in general adult and haematological intensive care. He was awarded a Medical Research Council Research Training Fellowship for his work on the pathophysiology of sepsis at University College, London and Yale Universities which he completed with Professor Mervyn Singer. His ongoing research interests focus on improving patient safety and care through development of innovative technologies.
Ashleigh is an RCEM credentialed Advanced Clinical Practitioner in Adults and Paeds Emergency Medicine in the Royal Air Force, currently working in Oxford. She has recently handed over the role of RCEM ACP forum Chair after 3 years. Her main clinical interests are trauma leadership and increasingly emergency department leadership. When not at work or on a teams meeting she can be found walking her dog or perhaps trying a new craft beer.
Dr. Carlos Ferreira is a General Surgeon specializing in trauma and emergency medicine, practicing at Hospital da Luz in Lisbon. Since 2014, he has served as a trauma surgeon with the International Committee of the Red Cross (ICRC), deploying in high-conflict areas including South Sudan, Goma, Iraq, Yemen, Ukraine, and the Gaza Strip.
From 2018, Dr. Carlos Ferreira has also provided trauma surgical support with Médecins Sans Frontières (MSF) in France, contributing to missions in Iraq and Republic of the Congo.
Earlier in his career, he was an operative physician at INEM, serving on VMER, CODU, and SHEM emergency response units.
He holds a Master's in Trauma (FMUP), a second Master's in Disaster and Conflict Medicine (FCM-UNL), and is a certified instructor for the Definitive Surgical Trauma Care (DSTC) course
Laureates of the most important distinctions in the Life Sciences’ field, eminent researchers and remarkable doctors will give us a rare glimpse into the hard work behind some of the major discoveries of our time. Listen to their story of what it took to get there.
Currently serving at the US Government's Advanced Research Projects Agency for Health (ARPA-H), Dr. Haider Warraich is the author of over 180 peer reviewed papers, three internationally-
-published, critically-acclaimed books (Modern Death, State of the Heart, The Song of Our Scars) and has written frequently for the New York Times and Washingon Post, among others.
Before this role, he served at the U.S. Food and Drug Administration as a Senior Clinical Advisor for Chronic Disease to the FDA Commissioner, was a faculty member at Harvard Medical School and Brigham and Women's Hospital and
Heart Director of the Heart Failure Program, at the Veterans Affairs Health System in Boston.
As we say in Portuguese, “The doctor who only knows about Medicine, doesn’t know it at all” (Professor Abel Salazar 1889 – 1946). The iMed Sessions are a set of lectures meant to connect the world of medicine and the world beyond it, thus fulfilling the main goal of the iMed Conference® – to INSPIRE.
Professor Jag Dhanda is an OMFS/HN Consultant Surgeon.
Professor of Surgery and Professor of Extended Reality in Medicine and Surgery. His surgical practice is free tissue transfer for complex head and neck reconstruction. He received three RCSEng research fellowships for his PhD. Professor Dhanda is the founder and CEO for Virtual Reality in Medicine and Surgery (VRiMS.net), a training resource using extended reality to train surgeons of all surgical specialties in the UK and globally. He is conducting studies to evaluate extended reality in medical education and regularly travels to low to middle income countries develop teaching resources using extended reality.
Luca Alfatti MSc, BSc (HONS), FRRHH, FRGS, FEWM, MCPara
Global Head of Education & Training, Gibb Medical and Rescue | Co-Founder, World Extreme Medicine Fund | Founder, Great Italian Outdoors
Luca Alfatti is an internationally recognised Advanced Paramedic, educator, and humanitarian leader with over 15 years of experience in clinical medicine, expeditionary operations, and global crisis response. He has led medical training and operations in over 100 countries, including extreme environments such as deserts, polar regions, and conflict zones. Luca co-founded the World Extreme Medicine Fund, delivering millions in medical supplies and training to crisis-affected communities. He is a Fellow of the Royal Geographical Society, the Faculty of Extreme Wilderness Medicine, and the Faculty of Remote, Rural and Humanitarian Healthcare.
For these lectures we choose speakers who have devoted their lives to humanitarian Medicine – our aim is to motivate students to be connected with the world beyond their hospitals and take action. In today’s global world, where problems have no borders anymore, what role will you play?
Sonia Adesara is a doctor, campaigner and previously worked in national health policy as the National Medical Director's Clinical Fellow. She has written extensively on issues of migrants' rights and reproductive justice, and regularly features on UK and international broadcast media discussing health and politics. She currently serves as chair of Society, a progressive policy think-tank. She is spokesperson for Doctors for Choice UK, an organisation that campaigns for the decriminalisation of abortion. is the Non-Executive Director for Health at UKActive and serves on the Board of Trustees for Medact, a charity that supports healthcare professionals in addressing the social determinants of health.
A leading international public health expert with over 30 years of experience at WHO, national and city governments, and global institutions. His expertise spans health policy and strategy, health diplomacy, governance, social determinants, health inequalities, migration, climate change, urban health, and public health systems. He led the European Health 2020 strategy, co-founded the WHO Healthy Cities Movement, and integrated social determinants into WHO policy. He has also served as President of the Greek CDC and the Greek National Board of Public Health, making significant contributions to health policy at national, regional, and global levels. He continues to advise on transformative approaches to strengthen health systems and address emerging global health challenges.